About Access Accelerated
Founded in 2017 at the World Economic Forum, Access Accelerated is a collective of leading biopharmaceutical and life science companies working to advance action for NCDs. Fueled by the belief that all people should have access to quality NCD prevention, treatment and care, we implement scalable solutions through partnerships that address barriers to NCD care.
As an industry-led initiative, Access Accelerated provides a structure for cooperation across sectors and actors, including implementors, decision-makers and financers. Together, we support our strategic partner, the World Bank, to increase access to NCD services in low- and middle-income countries. Our multi-disciplinary expertise spans a wide range of therapeutic areas and our collective insights stem from more than 100 public health programs that we operate around the world.
Underlying our work is our commitment to supporting the United Nations Sustainable Development Goals (SDGs), in particular, the target to reduce premature deaths from NCDs by one-third by 2030 (3.4) and the target to strengthen the means of implementation and global partnership (17).
Access Accelerated is headquartered in Geneva, Switzerland
AMPATH team members at a clinic in Kitale, Kenya (2019)
IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.
We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.
To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.
Some of our web pages utilise “cookies”. A “cookie” is a small text file that may be used, for example, to collect information about web site activity. Some cookies and other technologies may serve to recall Personal Information previously indicated by a web user. Most browsers allow you to control cookies, including whether or not to accept them and how to remove them.
Some cookies are necessary for the operation of our website, if you choose to block them some aspects of the site may not work for you. Non necessary cookies are only set when you have given your explicit consent to their use. Such cookies included those set by our statistics package Google Analytics.
We are committed to privacy and support current industry initiatives to preserve individual privacy rights on the Internet. Protecting your privacy on-line is an evolving area and this website will constantly evolve to meet these demands.